ShowcasesPricing
  1. US-listed companies
  2. Revance Therapeutics, Inc.

Revance Therapeutics, Inc.RVNC

Market cap
$292.87M
P/E ratio
Income statementBalance sheetCash flowOther
Raw aggregated data